rs2307456

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006502.3(POLH):​c.626G>T​(p.Gly209Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00327 in 1,613,940 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 12 hom. )

Consequence

POLH
NM_006502.3 missense

Scores

5
8
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 7.62
Variant links:
Genes affected
POLH (HGNC:9181): (DNA polymerase eta) This gene encodes a member of the Y family of specialized DNA polymerases. It copies undamaged DNA with a lower fidelity than other DNA-directed polymerases. However, it accurately replicates UV-damaged DNA; when thymine dimers are present, this polymerase inserts the complementary nucleotides in the newly synthesized DNA, thereby bypassing the lesion and suppressing the mutagenic effect of UV-induced DNA damage. This polymerase is thought to be involved in hypermutation during immunoglobulin class switch recombination. Mutations in this gene result in XPV, a variant type of xeroderma pigmentosum. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017212152).
BP6
Variant 6-43597831-G-T is Benign according to our data. Variant chr6-43597831-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 259990.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-43597831-G-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.00332 (4852/1461672) while in subpopulation SAS AF= 0.0101 (868/86256). AF 95% confidence interval is 0.00951. There are 12 homozygotes in gnomad4_exome. There are 2591 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POLHNM_006502.3 linkuse as main transcriptc.626G>T p.Gly209Val missense_variant 5/11 ENST00000372236.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POLHENST00000372236.9 linkuse as main transcriptc.626G>T p.Gly209Val missense_variant 5/111 NM_006502.3 P1Q9Y253-1
POLHENST00000372226.1 linkuse as main transcriptc.626G>T p.Gly209Val missense_variant 5/111 Q9Y253-2

Frequencies

GnomAD3 genomes
AF:
0.00281
AC:
427
AN:
152150
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00125
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.00951
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00307
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00378
AC:
951
AN:
251482
Hom.:
3
AF XY:
0.00433
AC XY:
588
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00367
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.0101
Gnomad FIN exome
AF:
0.00735
Gnomad NFE exome
AF:
0.00325
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00332
AC:
4852
AN:
1461672
Hom.:
12
Cov.:
31
AF XY:
0.00356
AC XY:
2591
AN XY:
727148
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.00119
Gnomad4 ASJ exome
AF:
0.00406
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0101
Gnomad4 FIN exome
AF:
0.00666
Gnomad4 NFE exome
AF:
0.00288
Gnomad4 OTH exome
AF:
0.00361
GnomAD4 genome
AF:
0.00280
AC:
427
AN:
152268
Hom.:
4
Cov.:
32
AF XY:
0.00338
AC XY:
252
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.000481
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00403
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0108
Gnomad4 FIN
AF:
0.00951
Gnomad4 NFE
AF:
0.00307
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00270
Hom.:
1
Bravo
AF:
0.00224
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00337
AC:
29
ExAC
AF:
0.00341
AC:
414
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00507
EpiControl
AF:
0.00504

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Xeroderma pigmentosum variant type Benign:5
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical CenterSep 17, 2017- -
not specified Benign:3
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 13, 2022Variant summary: POLH c.626G>T (p.Gly209Val) results in a non-conservative amino acid change located in the UmuC domain (IPR001126) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0038 in 251482 control chromosomes, predominantly at a frequency of 0.01 within the South Asian subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 34-fold of the estimated maximal expected allele frequency for a pathogenic variant in POLH causing Xeroderma Pigmentosum phenotype (0.0003), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.626G>T has been reported in the literature in individuals affected with melanoma and suspected HBOC (Potjer_2019, Moradian_2021). These reports do not provide unequivocal conclusions about association of the variant with Xeroderma Pigmentosum. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 06, 2019This variant is associated with the following publications: (PMID: 30414346) -
Benign, criteria provided, single submitterclinical testingInvitaeJan 29, 2024- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2024POLH: BS1, BS2 -
Xeroderma pigmentosum Benign:1
Benign, criteria provided, single submittercurationSema4, Sema4Feb 18, 2021- -
Malignant tumor of breast Benign:1
Benign, no assertion criteria providedclinical testingCenter of Medical Genetics and Primary Health Care-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.082
T
BayesDel_noAF
Uncertain
0.12
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.71
D;.
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Benign
0.064
D
MetaRNN
Benign
0.017
T;T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Pathogenic
4.2
H;H
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.44
T
PROVEAN
Pathogenic
-8.1
D;D
REVEL
Uncertain
0.62
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
D;.
Vest4
0.64
MVP
0.96
MPC
0.87
ClinPred
0.12
T
GERP RS
5.4
Varity_R
0.90
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2307456; hg19: chr6-43565568; API